Drug Usage Statistics, United States, 2006 - 2016

Number of Prescriptions Over Time (2006 - 2016)

Rank of Top Drugs Over Time

"Rank" refers to the frequency that a given medication is prescribed within a calendar year compared to all other medications. A rank of "4" would indicate that the medication was the fourth most commonly prescribed medication.

Year Rank Change
2006 85  8
2007 81  4
2008 89  8
2009 113  24
2010 136  23
2011 189  53
Year Rank Change
2012 224  35
2013 299  75
2014 286  13
2015 267  19
2016 339  72

Patient Out-Of-Pocket Cost Over Time (2006 - 2016)

"Out-of-pocket" cost refers to the payment made by the patient (either cash price or the copay amount). This value does not include reimbursement from a third party payer (eg, Medicare or private insurance) and does not represent the total drug cost.

Usage Statistics of Related Drugs

Drug Name Total Prescriptions (2016)
Alendronate Sodium 10,576,012
Ibandronate Sodium 1,073,985
Risedronate (this drug) 948,955

Drug Synonyms

Drug synonyms are used during the sanitation and standardization process of "cleaning" the original data source (MEPS). Occassionally, brand names may be listed below that are no longer on the market or are very infrequently used.

Brand Name Synonyms
  • Actonel
  • Atelvia
Generic Drug Synonyms and Salts
  • Risedronate Sodium
  • Risedronate Sodium Monohydrate
  • Risedronate

FDA Approval Information

Established Pharmacologic Class (EPC): Bisphosphonate
Initial FDA approval date: 3/27/1998
First FDA applicant: Rx
First dosage form: Tablet (oral)

Prescription data source: Medical Expenditure Panel Survey (MEPS) 2006-2016. Agency for Healthcare Research and Quality (AHRQ), Rockville, MD. ClinCalc DrugStats Database version 19.1. Read more about the ClinCalc DrugStats database.


Related Links

Follow Us!

New and Popular


Open Menu

Cite This Page

Show AMA citation

Learning from notecards is so 1900s... Quickly learn drug therapy with our HD videos. The Top 250 Drugs by ClinCalc Academy
©2019 - ClinCalc LLC. All rights reserved.
Disclaimer - Privacy Policy - Contact Us
Updated Jul 19, 2018
Back to Top